Cancer Archive — Page 24 of 68
-
January 27, 2022
New fund supports appendiceal cancer research
-
January 25, 2022
Comprehensive framework outlined for addressing early-onset colorectal cancer research
New research from Vanderbilt sets a comprehensive framework for addressing research challenges and patient needs for people under 50 with colorectal cancer. -
January 19, 2022
Clinical score can guide PRRT therapy decisions for neuroendocrine tumors
A clinical score system developed by researchers at Vanderbilt-Ingram Cancer Center (VICC) has been validated that can guide peptide receptor radionuclide therapy treatment decisions. -
January 17, 2022
H. pylori, lipid loss and stomach cancer
H. pylori infection — a strong risk factor for stomach cancer — changes the composition of stomach lipids, which could offer new biomarkers for detecting premalignant changes, Vanderbilt researchers discovered. -
January 14, 2022
Vanderbilt biostatisticians launch Cancer-Immu data portal for predicting response to immune checkpoint blockade immunotherapy
A new data portal called Cancer-Immu established by a team of Vanderbilt University Medical Center biostatisticians can help cancer clinicians and researchers predict which patients will respond to immune checkpoint inhibitors. -
January 13, 2022
Study seeks to refine head and neck cancer treatment options
-
January 5, 2022
Drug modifies epigenome in aggressive brain tumors: study
A folic acid-like drug changed a DNA process within brain tumors of glioblastoma patients, according to results from a phase 1 clinical trial.